1. 疾病领域
  2. 泌尿生殖系统疾病
  3. 泌尿生殖系统癌症

Urogenital Cancer  (泌尿生殖系统癌症)

泌尿生殖系统癌症涵盖影响男性和女性泌尿系统以及男性生殖器官的恶性肿瘤。在男性中,这些癌症包括前列腺癌、膀胱癌、肾癌、肾上腺癌、尿道癌、阴茎癌和睾丸癌。在女性中,生殖器官癌症被单独归类为妇科癌症。这些癌症源于泌尿生殖道(包括肾脏、膀胱、输尿管、尿道、前列腺、睾丸和阴茎)的异常细胞生长。

Genitourinary cancers encompass malignancies affecting the urinary system in both men and women, as well as male reproductive organs. In men, these include prostate, bladder, kidney, adrenal gland, urethra, penile, and testicular cancers. In women, cancers of the reproductive organs are classified separately as gynecologic cancers. These cancers arise from abnormal cell growth in the genitourinary tract, including the kidneys, bladder, ureters, urethra, prostate, testes, and penis.

参考文献:

Urogenital Cancer (1):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-17386
    Rosiglitazone

    罗格列酮

    122320-73-4 99.94%
    Rosiglitazone (BRL 49653) 是一种具有口服活性的 PPARγ 选择性激动剂 (EC50: 60 nM, Kd: 40 nM)。Rosiglitazone 是一种 TRPC5 激活剂 (EC50: 30 μM) 和 TRPM3 抑制剂。Rosiglitazone 可用于肥胖、糖尿病、衰老、卵巢癌的研究。
    Rosiglitazone